From: Analysis of urinary exosomal metabolites identifies cardiovascular risk signatures with added value to urine analysis
Control subjects
CABG patients
Age
49 ± 6
68 ± 9
Sex (% male)
43
52
Diabetes (%)
0
26
Hypertension (%)
89
Previous coronary event (%)
56
Dyslipidemia
78
PVD
15